BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fourgeaud L, Dvorak C, Faouzi M, Starkus J, Sahdeo S, Wang Q, Lord B, Coate H, Taylor N, He Y, Qin N, Wickenden A, Carruthers N, Lovenberg TW, Penner R, Bhattacharya A. Pharmacology of JNJ-28583113: A novel TRPM2 antagonist. Eur J Pharmacol 2019;853:299-307. [PMID: 30965058 DOI: 10.1016/j.ejphar.2019.03.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z. Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors. Eur J Med Chem 2021;225:113750. [PMID: 34416664 DOI: 10.1016/j.ejmech.2021.113750] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Thompson B, Satin LS. Beta-Cell Ion Channels and Their Role in Regulating Insulin Secretion. Compr Physiol 2021;11:1-21. [PMID: 34636409 DOI: 10.1002/cphy.c210004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Koivisto AP, Belvisi MG, Gaudet R, Szallasi A. Advances in TRP channel drug discovery: from target validation to clinical studies. Nat Rev Drug Discov 2021. [PMID: 34526696 DOI: 10.1038/s41573-021-00268-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 41] [Article Influence: 1.0] [Reference Citation Analysis]
4 García-Rodríguez C, Bravo-Tobar ID, Duarte Y, Barrio LC, Sáez JC. Contribution of non-selective membrane channels and receptors in epilepsy. Pharmacol Ther 2021;:107980. [PMID: 34481811 DOI: 10.1016/j.pharmthera.2021.107980] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Ali ES, Rychkov GY, Barritt GJ. TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species. Antioxidants (Basel) 2021;10:1243. [PMID: 34439491 DOI: 10.3390/antiox10081243] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Zielińska W, Zabrzyński J, Gagat M, Grzanka A. The Role of TRPM2 in Endothelial Function and Dysfunction. Int J Mol Sci 2021;22:7635. [PMID: 34299254 DOI: 10.3390/ijms22147635] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, Xu Q, Jin H, Liu Z, Yang W, Zhang L. The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo. J Med Chem 2021;64:3976-96. [PMID: 33784097 DOI: 10.1021/acs.jmedchem.0c02129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Wang Q, Liu N, Ni YS, Yang JM, Ma L, Lan XB, Wu J, Niu JG, Yu JQ. TRPM2 in ischemic stroke: Structure, molecular mechanisms, and drug intervention. Channels (Austin) 2021;15:136-54. [PMID: 33455532 DOI: 10.1080/19336950.2020.1870088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Malko P, Jiang LH. TRPM2 channel-mediated cell death: An important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions. Redox Biol 2020;37:101755. [PMID: 33130440 DOI: 10.1016/j.redox.2020.101755] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
10 Zhang H, Zhao S, Yu J, Yang W, Liu Z, Zhang L. Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading? Drug Discov Today 2020;25:2326-34. [PMID: 33065292 DOI: 10.1016/j.drudis.2020.09.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Pallagi P, Madácsy T, Varga Á, Maléth J. Intracellular Ca2+ Signalling in the Pathogenesis of Acute Pancreatitis: Recent Advances and Translational Perspectives. Int J Mol Sci 2020;21:E4005. [PMID: 32503336 DOI: 10.3390/ijms21114005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
12 Islam MS. Molecular Regulations and Functions of the Transient Receptor Potential Channels of the Islets of Langerhans and Insulinoma Cells. Cells 2020;9:E685. [PMID: 32168890 DOI: 10.3390/cells9030685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
13 Cruz-Torres I, Backos DS, Herson PS. Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX. Mol Pharmacol 2020;97:102-11. [PMID: 31772034 DOI: 10.1124/mol.119.117549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
14 Huang Y, Roth B, Lü W, Du J. Ligand recognition and gating mechanism through three ligand-binding sites of human TRPM2 channel. Elife 2019;8:e50175. [PMID: 31513012 DOI: 10.7554/eLife.50175] [Cited by in Crossref: 29] [Cited by in F6Publishing: 40] [Article Influence: 9.7] [Reference Citation Analysis]
15 Dietz RM, Cruz-Torres I, Orfila JE, Patsos OP, Shimizu K, Chalmers N, Deng G, Tiemeier E, Quillinan N, Herson PS. Reversal of Global Ischemia-Induced Cognitive Dysfunction by Delayed Inhibition of TRPM2 Ion Channels. Transl Stroke Res 2020;11:254-66. [PMID: 31250378 DOI: 10.1007/s12975-019-00712-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]